drugset / Trial / NCT00736151
Phase II Dose Titration Study in Patients With Neuropathic Pain
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of this study is to examine the effects of various increasing doses of Ralfinamide in patients with neuropathic pain.
Timeline
- Start
- 2004-05
- Primary completion
- 2007-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ralfinamide | Small molecule | 80 mg | Oral |
| Subject | Ralfinamide | Small molecule | 160 mg | Oral |
| Subject | Ralfinamide | Small molecule | 240 mg | Oral |
| Subject | Ralfinamide | Small molecule | 320 mg | Oral |